Skip to main navigation Skip to search Skip to main content

Co-delivery of hydrophobic and hydrophilic drugsfrom nanoparticle-aptamer bioconjugates

  • Liangfang Zhang
  • , Aleksandar F. Radovic-Moreno
  • , Frank Alexis
  • , Frank X. Gu
  • , Pamela A. Basto
  • , Vaishali Bagalkot
  • , Sangyong Jon
  • , Robert S. Langer
  • , Omid C. Farokhzad
  • Massachusetts Institute of Technology
  • Brigham and Women's Hospital
  • Gwangju Institute of Science and Technology

Research output: Contribution to journalArticlepeer-review

262 Scopus citations

Abstract

(Figure Presented) Herein we report a novel targeted drug delivery system consisting of nanoparticle-aptamer bioconjugates,which can carry both hydrophobic and hydrophilic chemotherapeutic drugs simultaneously, and deliver them selectively in a targeted and temporally distinct manner. This work provides a robust platform for targeted co-delivery of chemotherapeutic agents with the hope of both leveraging the synergistic effects of multiple drugs and also potentially suppressing the likelihood of drug resistance by the treated tissues.

Original languageEnglish
Pages (from-to)1268-1271
Number of pages4
JournalChemMedChem
Volume2
Issue number9
DOIs
StatePublished - 10 Sep 2007
Externally publishedYes

Keywords

  • Antitumor agents
  • Conjugation
  • Dual drug delivery
  • Nanoparticles
  • Targeted therapy

Fingerprint

Dive into the research topics of 'Co-delivery of hydrophobic and hydrophilic drugsfrom nanoparticle-aptamer bioconjugates'. Together they form a unique fingerprint.

Cite this